Matthew McManus

Matthew McManus

Chairman at
Ansa Biotechnologies, Inc.

Net worth: 397 471 $ as of 30/05/2026

57 year
Health Technology
Consumer Services
Health Services

Profile

Matthew F.
McManus
is currently Chairman at Ansa Biotechnologies, Inc. since 2023.
Former roles include President, Chief Executive Officer & Director at PrimeraDx, Inc. from 2010 to 2014; President, Chief Executive Officer & Director at Asuragen, Inc. from 2014 to 2021; Chief Operating Officer & Executive Vice President at Azenta, Inc. in 2022; COO-Pathology and Laboratory Medicine Institute at The Cleveland Clinic Foundation in 2010; President-Diagnostics & Spatial Biology Segment at Bio-Techne Corp.
from 2024 to 2026; Manager-Business Unit at Procter & Gamble Co.; Management Consultant at McKinsey & Co., Inc.; and Medical Scientist at Novartis Institutes for Biomedical Research, Inc. Education includes undergraduate studies at College of the Holy Cross (Massachusetts), an MBA from Boston College, and a doctorate from the University of Pennsylvania Medical Center.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/01/2026 7,691 ( 0% ) 397 471 $ 30/05/2026

Latest news about Matthew McManus

Matthew McManus active positions

CompaniesPositionStart
Chairman 21/02/2023

Former positions of Matthew McManus

CompaniesPositionEnd
BIO-TECHNE CORPORATION Corporate Officer/Principal 28/02/2026
AZENTA, INC. Chief Operating Officer 13/10/2022
Chief Executive Officer -
Corporate Officer/Principal 01/01/2010
PROCTER & GAMBLE COMPANY Corporate Officer/Principal -
See the detail of Matthew McManus's experience

Training of Matthew McManus

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

19

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Consumer Non-Durables

Health Technology

Health Services

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Commercial Services

Health Services

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Matthew McManus